Cleared Traditional

K072149 - ELIA SYMPHONY IMMUNOASSAY, ANA CONTROL, MODEL 14-55508-01,83-1004-01

K072149 is an FDA 510(k) clearance for ELIA SYMPHONY IMMUNOASSAY, manufactured by Phadia US, Inc.. The device is a Class 2 Immunology device with product code LLL cleared through the Traditional 510(k) pathway after a 165-day FDA review.

K072149 · Phadia US, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2008
Decision
165d
Days
Class 2
Risk

K072149 is an FDA 510(k) clearance for the ELIA SYMPHONY IMMUNOASSAY, ANA CONTROL, MODEL 14-55508-01,83-1004-01. Classified as Extractable Antinuclear Antibody, Antigen And Control (product code LLL), Class II - Special Controls.

Submitted by Phadia US, Inc. (Portage, US). The FDA issued a Cleared decision on January 15, 2008 after a review of 165 days - an extended review cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5100 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Phadia US, Inc. devices

FDA 510(k) Submission Details - K072149

510(k) Number K072149 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 03, 2007
Decision Date January 15, 2008
Days to Decision 165 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
60d slower than avg
Panel avg: 105d · This submission: 165d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLL Device Classification - Class 2, Special Controls

Product Code LLL Extractable Antinuclear Antibody, Antigen And Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - LLL Extractable Antinuclear Antibody, Antigen And Control

All 152
Devices cleared under the same product code (LLL) and FDA review panel - the closest regulatory comparables to K072149.
EUROIMMUN ANTI-ENA POOL ELISA (IGG)
K112996 · Euroimmun US · Apr 2013
IMMULISA SCI-70 ANTIBODY ELISA
K113143 · Immco Diagnostics, Inc. · Dec 2011
FIDISTM CONNECTIVE 10, FIDISTM ANALYZER, CARIS
K102607 · Biomedical Diagnostics (Bmd) SA · Dec 2010
FIDIS CONNECTIVE 10, MODEL MX006
K053653 · Biomedical Diagnostics (Bmd) SA · Mar 2006
FIDIS CONNECTIVE 8
K050286 · Biomedical Diagnostics (Bmd) SA · Oct 2005
ENA IGG BEADCHIP TEST SYSTEM, ARRAY IMAGING SYSTEM, MODELS 800-00025, AIS 400
K043067 · Bioarray Solutions, Ltd. · May 2005